Publication, Part of National Diabetes Audit: Non-Diabetic Hyperglycaemia, Diabetes Prevention Programme
Non-Diabetic Hyperglycaemia, 2020-21, Diabetes Prevention Programme
Introduction
Acronym key
Non-diabetic hyperglycaemia
| Status | HbA1c (mmol/mol) | FPG (mmol/L) |
| Normal | <=41 | <=5.4 |
| NDH | 42 to 47 | 5.5 to 6.9 |
| Type 2 diabetes | >=48 | >=7.0 |
Table 1: Registrations and prevalence1, GP-recorded non-diabetic hyperglycaemia (NDH) and type 2 diabetes, 2020-21, England.
| Registered at GP practice | Diagnosis of Type 2 diabetes recorded | Diagnosis of non-diabetic hyperglycaemia recorded | ||
| Number | Per cent | Number | Per cent | |
| 48,753,835 | 3,218,925 | 6.6% | 2,378,485 | 4.9% |
The Office for Health Inequalities and Disparities (OHID, formally Public Health England)
Estimated that there are 4 million people with type 2 diabetes and 5 million people with non-diabetic hyperglycaemia in England.
Footnotes
1. People included: those registered at a GP practice that participated in NDA 2020-21.
2. Public Health England (2015): Diabetes prevalence estimates for local populations and Analysis of non-diabetic hyperglycaemia prevalence in England.
Last edited: 21 July 2023 1:06 pm